BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27199760)

  • 1. Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease.
    Chiarini A; Armato U; Liu D; Dal Prà I
    Front Physiol; 2016; 7():134. PubMed ID: 27199760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing the spread of Alzheimer's disease neuropathology: a role for calcilytics?
    Chiarini A; Gardenal E; Whitfield JF; Chakravarthy B; Armato U; Dal Pra I
    Curr Pharm Biotechnol; 2015; 16(8):696-706. PubMed ID: 25941885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Human Astrocytes' Calcium-sensing Receptors for Treatment of Alzheimer's Disease.
    Chiarini A; Armato U; Whitfield JF; Pra ID
    Curr Pharm Des; 2017; 23(33):4990-5000. PubMed ID: 28699522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer's Disease.
    Dal Prà I; Chiarini A; Pacchiana R; Gardenal E; Chakravarthy B; Whitfield JF; Armato U
    Curr Neuropharmacol; 2014 Jul; 12(4):353-64. PubMed ID: 25342943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-Sensing Receptor Antagonist NPS 2143 Restores Amyloid Precursor Protein Physiological Non-Amyloidogenic Processing in Aβ-Exposed Adult Human Astrocytes.
    Chiarini A; Armato U; Liu D; Dal Prà I
    Sci Rep; 2017 Apr; 7(1):1277. PubMed ID: 28455519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?
    Dal Prà I; Chiarini A; Gui L; Chakravarthy B; Pacchiana R; Gardenal E; Whitfield JF; Armato U
    Neuroscientist; 2015 Feb; 21(1):9-29. PubMed ID: 24740577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaSR Antagonist (Calcilytic) NPS 2143 Hinders the Release of Neuroinflammatory IL-6, Soluble ICAM-1, RANTES, and MCP-2 from Aβ-Exposed Human Cortical Astrocytes.
    Chiarini A; Armato U; Hu P; Dal Prà I
    Cells; 2020 Jun; 9(6):. PubMed ID: 32498476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's Therapy.
    Chiarini A; Armato U; Gardenal E; Gui L; Dal Prà I
    Front Neurosci; 2017; 11():217. PubMed ID: 28473749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family C G-Protein-Coupled Receptors in Alzheimer's Disease and Therapeutic Implications.
    Dal Prà I; Armato U; Chiarini A
    Front Pharmacol; 2019; 10():1282. PubMed ID: 31719824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-sensing receptor (CaSR) in human brain's pathophysiology: roles in late-onset Alzheimer's disease (LOAD).
    Chiarini A; Dal Pra I; Marconi M; Chakravarthy B; Whitfield JF; Armato U
    Curr Pharm Biotechnol; 2009 Apr; 10(3):317-26. PubMed ID: 19355942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Aβ peptides-activated calcium-sensing receptor stimulates the production and secretion of vascular endothelial growth factor-A by normoxic adult human cortical astrocytes.
    Dal Prà I; Armato U; Chioffi F; Pacchiana R; Whitfield JF; Chakravarthy B; Gui L; Chiarini A
    Neuromolecular Med; 2014 Dec; 16(4):645-57. PubMed ID: 24948534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonizing amyloid-β/calcium-sensing receptor signaling in human astrocytes and neurons: a key to halt Alzheimer's disease progression?
    Dal Prà I; Chiarini A; Armato U
    Neural Regen Res; 2015 Feb; 10(2):213-8. PubMed ID: 25883618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.
    Zhao J; O'Connor T; Vassar R
    J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts of how β-amyloid proteins and pro-inflammatory cytokines might collaborate to produce an 'Alzheimer brain' (Review).
    Dal Pra I; Chiarini A; Pacchiana R; Chakravarthy B; Whitfield JF; Armato U
    Mol Med Rep; 2008; 1(2):173-8. PubMed ID: 21479393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of amyloid β (Aβ)42 and Gasdermin D on the progression of Alzheimer's disease
    Hong W; Hu C; Wang C; Zhu B; Tian M; Qin H
    Aging (Albany NY); 2023 Nov; 15(21):12209-12224. PubMed ID: 37921870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.
    Standridge JB
    Curr Alzheimer Res; 2006 Apr; 3(2):95-108. PubMed ID: 16611010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.